What is the Global Partnership to Stop TB?
Established in 2000 by the World Health Assembly, The Global Partnership to Stop TB is a global movement to accelerate social and political action to stop the unnecessary spread of tuberculosis around the world. The partnership responds to the Amsterdam Declaration to Stop TB, which served as a call to action to eliminate the disease. The targets of the partnership are as follows:
- By 2005: 70% of people with infectious TB will be diagnosed and 85% of them cured
- By 2015: the global burden of TB disease (deaths and prevalence) will be reduced by 50% relative to 1990 levels
- By 2050: to eliminate TB as a global public health problem
To reach these targets, the Global Partnership to Stop TB has three goals
- To promote wider and wiser use of existing strategies to interrupt TB transmission
- To adapt existing strategies to address the challenges posed by emergency threats
- To accelerate elimination of TB
Stop TB’s Global Plan serves as a detailed description of their strategy for achieving the Stop TB Partnership's global TB control targets for 2015 (linked to the Millennium Development Goals), which contribute to their ultimate goals in 2050.
How does StopTB work?
A Partners’ Forum, Coordinating Board, Working Groups, and Secretariat form the structure of Stop TB. The Partners’ Forum meets every three years in a consultative meeting to review actions related to the organization’s mission and make recommendations. In addition, the Board approves and oversees the work plan and budget, mobilizes resources, coordinates and promotes advocacy at all levels, and reviews and reports on progress. Anyone can participate in the meeting, and care is taken to ensure high burden countries are represented.
Staffed by secondments from partner organizations, the Secretariat aims at facilitating, creating synergies and adding value to the work that the remainder of StopTB does. Accountable to the Coordinating Board, the Secretariat’s aims to implement in the most effective ways available the tasks assigned by the Coordinating Board.
There are six working groups (new drugs, DOTS expansion, TB/HIV, DOTS plus, TB diagnostics, TB vaccine development) that coordinate activities mandated by the Board. Their work consists in implementing any research, advocacy and operational activities relevant to their appropriate area aims, and collaborating and complementing the other facets of the Stop TB partnership to further overall goals.
What donors and other global partners contribute to, or play a major role in StopTB?
The Global Partnership to Stop TB is comprised of a network of organizations, countries, and donors from both the public and private sector. In all, there are over 250 partners committed to eliminating TB in the StopTB program, including the World Health Organization and the American Lung Association. WHO serves as a leading agency, provides guidance on global policy, and houses the Stop TB Partnership Secretariat.
What countries does StopTB support?
Stop TB focuses on countries with a high burden of TB disease. Twenty-two countries account for 80% of the world’s TB burden: Brazil, South Africa, Zimbabwe, Mozambique, Tanzania, Kenya, Ethiopia, Uganda, Democratic Republic of Congo, Nigeria, Russian Federation, China, India, Indonesia, Thailand, Cambodia, Viet Nam, Pakistan, Myanmar, Philippines, Afghanistan, and Bangladesh.
What are good sources of information about the Global Fund for AIDS, TB and Malaria?
The Global Fund’s Framework
GAVI 2004-2005 Work Plan
Questions & Answers about GAVI and the Vaccine Fund
Godal, Torre. GAVI, the first steps: lessons for the Global Fund. The Lancet, Vol 360. July 13, 2002.
Martin, Jacques-Francois and John Marshall. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund. Vaccine 21 (2003) 587-592.
Nossal, Gustav. Gates, GAVI, the glorious global funds and more: All you ever wanted to know. Immunology and Cell Biology (2003) 81, 20-22.
Wittet, Scott. Introducing GAVI and the Global Fund for Children's Vaccines. Vaccine 19 (2001) 385-386.